X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

IONS

Closed

Ionis Pharmaceuticals Inc

39.94
+0.43 (+1.09%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 39.51
Day's Range: 39.72 - 40.82
Send
When Written:
 
35.26
Ionis Pharmaceuticals Inc. is a biotechnology company based in Carlsbad, California, USA. It was founded in 1989 by Stanley T. Crooke and specializes in developing RNA-targeted therapeutics. The company's focus is on developing drugs for rare diseases, neurological disorders, and cardiovascular diseases.

Ionis Pharmaceuticals has a unique antisense technology that allows the company to target specific genes responsible for diseases. This technology has been used to develop several successful drugs, including Spinraza, the first FDA-approved treatment for spinal muscular atrophy.

Ionis Pharmaceuticals has partnerships with several pharmaceutical companies, including Biogen, Roche, and AstraZeneca. The company has a robust pipeline of drugs in various stages of development, including drugs for Huntington's disease, ALS, and cardiovascular diseases.

Ionis Pharmaceuticals has a market capitalization of over $10 billion and is listed on the NASDAQ stock exchange under the ticker symbol IONS.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X